Tag: 2009

Financial

Alphatec Spine Announces Fourth Quarter and Full Year 2009 Revenue and Financial Results

Annual Revenue of $132.2 Million — 30% Growth Vs 2008; 2009 Adjusted EBITDA of $15 Million CARLSBAD, Calif., Feb 23, 2010 (GlobeNewswire via COMTEX News Network) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for […]

Financial

Medtronic Third Quarter Revenue Increases 10% to $3.851 Billion; Raises Lower End of EPS Guidance for Current Fiscal Year

MINNEAPOLIS, Feb 23, 2010 (BUSINESS WIRE) — –International revenue of $1.615 billion grew 11% on a constant currency basis; 22% as reported –Free cash flow exceeds $1.3 billion; GAAP cash flow from operations of $1.488 billion –Worldwide ICD revenue growth of 5% on a constant currency basis; 9% as reported […]

Financial

Exactech 2009 Revenue Up 10% to $177M; Q4 Revenue Up 20% to $48.3M, EPS $0.04 includes Charge to Earnings for Estimated DOJ Settlement

GAINESVILLE, Fla., Feb 22, 2010 (BUSINESS WIRE) — Exactech, Inc. (EXAC 18.25, +0.15, +0.83%), a developer and producer of bone and joint restoration products for hip, knee, extremities, spine and biologic materials, announced today that revenue for 2009 increased 10% to $177.3 million from $161.7 million in 2008. Diluted earnings per share for […]

Financial

DJO Incorporated Announces Financial Results for Fourth Quarter and Fiscal Year 2009

SAN DIEGO–(BUSINESS WIRE)–DJO Incorporated (“DJO” or the “Company”), a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC (“DJOFL”), for the fourth quarter and fiscal year ended December 31, 2009. ReAble Therapeutics, Inc. (“ReAble”) […]

Financial

NeuroMetrix Reports 2009 Financial Results

WALTHAM, Mass.–(BUSINESS WIRE)–NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced its financial results for the three months and year ended December 31, 2009. Total revenues for the fourth quarter of 2009 were $6.2 million, compared with $7.2 million for the fourth quarter of […]

Financial

RTI Biologics Announces 2009 Year End, Fourth Quarter Results, Estimates 2010 Revenues and EPS

ALACHUA, Fla.–(BUSINESS WIRE)–RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading processor of orthopedic and other biologic implants, reported operating results for the fourth quarter and full year ending Dec. 31, 2009. Quarterly Highlights: Revenues of $42.0 million, an increase of 12 percent over the prior year period Net income of […]